Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × relatlimab × Tumor-Agnostic × Clear all

Phase

Status

Completed 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 12 Thoracic 3 Head & Neck 3 Genitourinary 3 Gastrointestinal 2 Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 26 Specimen Handling 18 Blood Specimen Collection 18 Magnetic Resonance Spectroscopy 17 Biopsy 16 Surveys and Questionnaires 12 atezolizumab 11 Bevacizumab 9 Radiosurgery 8 Paclitaxel 8 Fluorouracil 8 Standard of Care 7 Radiotherapy 7 Nivolumab 7 Irinotecan 7 Gemcitabine 7 Cisplatin 7 Carboplatin 7 durvalumab 6 Oxaliplatin 6 Leucovorin 6 Exercise 6 Cyclophosphamide 6 Capecitabine 6 olaparib 5 cabozantinib 5 alectinib 5 abemaciclib 5 Trastuzumab 5 Palliative Care 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03899155 2026-04-01

Pan Tumor Rollover Study

Bristol-Myers Squibb

Phase 2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡